Gastrointestinal Infection Testing Market To Stand Tall Amidst Personalized Continuing Medical Education, Reaching US$ 490.2 Mn

The global Gastrointestinal Infection Testing Market is expected to witness a CAGR of 4.9% and reach US$ 490.2 Mn by the year 2026. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's situation in the upcoming period.

According to the NCBI (National Center for Biotechnology Information), around 200 million GI illnesses occur in the United States each year. Gastrointestinal infection testing is performed to detect bacteria, viruses, and parasites. The growing frequency of gastrointestinal illnesses is increasing the number of Gastrointestinal Infection Testing, which will drive the growth of the gastrointestinal infection testing market over the forecast period.

Persistence Market Research's (PMR) recent report says that the global gastrointestinal infection testing market is expected to hit US$ 490.2 Mn by 2026. The gastrointestinal infection testing market is expected to have a CAGR of 4.9% during the forecast period of 2022-2026, according to the report.

Get a Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/17314

Company Profiles:

Becton, Dickinson and Company (BD)
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Luminex Corporation
Hoffmann-La Roche Ltd.
bioMérieux SA
Quidel Corporation
Illumina, Inc.
Seegene Inc
Genetic Signatures

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/17314

The Asia Pacific Region, Excluding China, will have the Highest Growth Rate

The Asia Pacific region, excluding China, is projected to have the highest growth rate because of a rising patient pool due to unhealthy lifestyles and inadequate sanitation facilities.

Apart from the Asia-Pacific region, the gastrointestinal infection testing market in North America is also expected to contribute to the global gastrointestinal infection testing market's growth due to the rising healthcare budget and initiatives to increase awareness and availability of quality gastrointestinal infection testing options in the region. However, the US FDA's stringent rules and regulations may impede the growth of the gastrointestinal infection testing market in this region.

The Impact of COVID-19 on the Global Gastrointestinal Infection Testing Market

In 2020, as COVID-19 cases began to peak, there was a decrease in the number of gastrointestinal infection testing due to Covid-19 restrictions and lockdowns. However, in 2021, when the Covid-19 restrictions were relaxed, the Gastrointestinal Infection Testing frequency began to rise.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/17314

Want More Insights?

PMR has presented a comprehensive report based on Gastrointestinal Infection Testing Market as per Product Type (Reagent Kits, Sequencing Kits, and Equipment), Disease Strains (Bacterial Strains, Viral Strains and Parasitic Strains), End User (Hospitals, Clinics/Medical Centers, Diagnostic Laboratories and Research Institutes), based on seven regions.

Access Related Reports-

Automated Esr Analyzer Market: https://www.persistencemarketresearch.com/market-research/automated-esr-analyzer-market.asp

Treponema Pallidum Tests Market: https://www.persistencemarketresearch.com/market-research/treponema-pallidum-tests-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.